title: Pentylenetetrazol-kindling of seizures selectively decreases [3H]-citalopram binding in the CA-3 area of rat hippocampus.
abstract: The present study was aimed at determining the changes in the 5-HT transporter activity, in different brain structures after pentylenetetrazol induced kindling of seizures. We examined [3H]-citalopram binding in the rat brain structures, and the neurodegenerative effects in the hippocampal formation using autoradiographic and immunohistochemical methods. A statistically significant and selective reduction in the binding of [3H]-citalopram was found in the CA3 field of the hippocampus (P=0.009), and a similar tendency, close to the significance level, in the dentate gyrus (P=0.05). This effect was accompanied by a loss of neurons and activation of microglia in the hippocampal formation. The present data suggest the important role for CA3- serotonergic innervation in pentylenetetrazol induced kindling of seizures.
authors.affiliation: Department of Experimental and Clinical Pharmacology, Medical University, 26/28 Krakowskie Przedmiescie Street, 00-927 Warsaw, Poland.
authors.forename: J
authors.initials: J
authors.lastname: Szyndler
authors.forename: T
authors.initials: T
authors.lastname: Wierzba-Bobrowicz
authors.forename: P
authors.initials: P
authors.lastname: Maciejak
authors.forename: M
authors.initials: M
authors.lastname: Siemiatkowski
authors.forename: P
authors.initials: P
authors.lastname: Rok
authors.forename: M
authors.initials: M
authors.lastname: Lehner
authors.forename: A I
authors.initials: AI
authors.lastname: Czlonkowska
authors.forename: A
authors.initials: A
authors.lastname: Bidzinski
authors.forename: A
authors.initials: A
authors.lastname: Wislowska
authors.forename: M
authors.initials: M
authors.lastname: Zienowicz
authors.forename: A
authors.initials: A
authors.lastname: Plaznik
mesh_terms: D000818:Animals; D001345:Autoradiography; D002352:Carrier Proteins / Q000378:metabolism*; D015283:Citalopram / Q000378:metabolism*; D003292:Convulsants; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism*; D007150:Immunohistochemistry; D007696:Kindling, Neurologic; D008297:Male; D008562:Membrane Glycoproteins / Q000378:metabolism*; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D010433:Pentylenetetrazole; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000139:chemically induced / Q000378:metabolism*; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism*; D014316:Tritium
chemical_list: D002352:Carrier Proteins; D015283:Citalopram; D003292:Convulsants; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D010433:Pentylenetetrazole; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; D014316:Tritium; C493232:Slc6a4 protein, rat